Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Drug Release Profiles of Different Drug-coated Balloon Platforms
Author(s): Torsten Heilmann , Christian Richter , Heiko Noack , et al Added: 3 years ago
Drug-coated balloons (DCBs) are a nascent technology gaining a lot of attention among cardiologists and angiologists worldwide. As opposed to drug-eluting stents (DES) they allow intraluminal drug application to diseased arterial tissue without leaving an implant such as a metal scaffold behind. This may be beneficial where a stent is already in place or where stenting is problematic due to… View more

Intervention
EuroPCR 22: EASTBOURNE Registry indicates Satefy of Sirolimus-Coated Balloon
Author(s): Bernardo Cortese Added: 1 year ago
Dr Bernardo Cortese (La Fondazione Ricerca e Innovazione Cardiovascolare, IT) discusses the findings from the EASTBOURNE Registry, a study that investigated the sirolimus-coated balloon in an all-comer population. Findings are positive in regard to the device's safety and efficacy profile, with no safety signals for bleeding and the primary endpoint of target lesion revascularization (TLR), was… View more

Intervention
Job title: Chairman of the Department of Vascular Surgery
Dr Sean Lyden is the Chairman of the Department of Vascular Surgery at Cleveland Clinic’s Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute. Dr Lyden earned his medical degree from the University of Cincinnati College of Medicine following an undergraduate degree from the University of Notre Dame. He served a residency in general surgery at the University of Tennessee Health… View more
Author(s): Bruno Scheller , Bodo Cremers , Stephanie Schmitmeier , et al Added: 3 years ago
Coronary angioplasty was introduced to clinical practice by Andreas Grüntzig in 1977.1 In the coronary field, the most important improvement in angioplasty has been achieved with the introduction of stents. A significant proportion of the complex modern coronary interventional techniques rely on stenting. Stenting overcomes recoil and dissections but not restenosis due to neointimal proliferation… View more

Intervention
View from the Thoraxcenter: TCT 23 Late-breaking Science Wrap Up
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 5 months ago
What are the top late-breaking trials from #TCT2023? TCT 2023 — Join interventional cardiologists, Prof Nicolas Van Mieghem and Dr Joost Daemen from the Thoraxcenter as they unpack the most impactful late-breaking clinical trials and science data from this year's Transcatheter Cardiovascular Therapeutics Conference. Dive into this practical and engaging discussion and learn more about the… View more

Intervention
TCT 23: 5 Trials That Changed My Practice
Author(s): Mirvat Alasnag Added: 5 months ago
TCT 23 - We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of the late-breaking trials that are expected to have an impact on interventional science and clinical practice. Trials covered in detail include: Agent IDE ALIGN-AR PARTNER 3 EVOLUT Low-Risk TRISCEND Recorded remotely from Jeddah, 2023. Editor: Jordan Rance Video Specialist:… View more

Intervention
Jack WC Tan
Research Area(s) / Expertise:

MI/ACS

Angiography

Peripheral Artery Disease - General

Intervention

 Job title: Head and Senior Consultant
Academic History Dr Jack Tan graduated from the Faculty of Medicine, the National University of Singapore in 1997. In 2007, he spent one year at UC Davis Medical Center, Sacramento with Dr John Laird to complete his peripheral vascular interventional program. He is doubly accredited for cardiology and intensive care medicine in Singapore. He is the deputy head of cardiology and director of the… View more
EuroPCR 23: EBC MAIN Three-Year Follow Up
Author(s): David Hildick-Smith Added: 11 months ago
EuroPCR 23 - Join us as we discover the latest findings from a three-year follow-up of the EBC MAIN Trial, as we interview Principal Investigator Dr David Hildick-Smith (Brighton and Sussex University Hospitals, UK) onsite at EuroPCR 23. The EBC Main Trial aimed to investigate the outcomes of single-stent versus dual-stent bifurcation treatment of distal left main coronary artery lesions. This… View more

Intervention
TCT 21: SCB Shows Similar Angiographic Outcomes to Paclitaxel DCB
Author(s): Bruno Scheller Added: 2 years ago
In this video, Professor Bruno Scheller (Saarland University, Saarbrücken, DE) sits down to discuss the one-year angiographic outcomes of two parallel randomized trials investigating the effectiveness off sirolimus-coated and paclitaxel-coated DCB's in the treatment of coronary in-stent restenosis. Findings suggest comparable outcomes in both devices. Discussion points: 1. Importance of this… View more

Intervention